Vukasin Paunovich Biography and Net Worth

Chief Technology Officer of LifeStance Health Group

Vaughn is an experienced health care technology executive with more than 25 years of experience leading digital transformation initiatives, enabling AI-powered insights and streamlining digital tools to enhance care delivery. As Chief Technology Officer at LifeStance, Vaughn leads the organization’s end-to-end technology strategy, ensuring a best-in-class digital experience for both patients and clinicians.

Prior to joining LifeStance, Vaughn served as Executive Vice President of Enterprise Platforms at Amwell, where he led the product and technology teams in driving digital transformation for clinicians, patients and payor and provider organizations. Earlier in his career, Vaughn spent a decade at UnitedHealth Group in various leadership roles, including Chief Information Officer of Optum Health, where he led technology and innovation initiatives across the provider and patient care ecosystem.

Vaughn holds a B.S. in International Finance from the University at Albany.

What is Vukasin Paunovich's net worth?: The estimated net worth of Vukasin Paunovich is at least $2.63 million as of September 2nd, 2026. Mr. Paunovich owns 205,379 shares of LifeStance Health Group stock worth more than $2,628,851 as of September 9th. This net worth evaluation does not reflect any other investments that Mr. Paunovich may own. Learn More about Vukasin Paunovich's net worth.
How do I contact Vukasin Paunovich?: The corporate mailing address for Mr. Paunovich and other LifeStance Health Group executives is , , . LifeStance Health Group can also be reached via phone at 602-767-2100 and via email at [email protected]. Learn More on Vukasin Paunovich's contact information.
Has Vukasin Paunovich been buying or selling shares of LifeStance Health Group?: Within the last three months, Vukasin Paunovich has sold $1,023,077.19 of LifeStance Health Group stock. Most recently, Vukasin Paunovich sold 42,067 shares of the business's stock in a transaction on Wednesday, September 2nd. The shares were sold at an average price of $12.87, for a transaction totalling $541,402.29. Following the completion of the sale, the chief technology officer now directly owns 205,379 shares of the company's stock, valued at $2,643,227.73. Learn More on Vukasin Paunovich's trading history.
Who are LifeStance Health Group's active insiders?: LifeStance Health Group's insider roster includes Robert Bessler (Director), Darren Black (Director), David Bourdon (CFO), Jeffrey Crisan (Director), Lisa Miller (Executive Vice President, Practice Operations), Kevin Mullins (Insider), Ryan Pardo (Chief Legal Officer), Anisha Patel-Dunn (Chief Medical Officer), Vukasin Paunovich (Chief Technology Officer), Danish Qureshi (President and Chief Operating Officer), Ujjwal Ramtekkar (Chief Medical Officer), Eric Shuey (Director), and Ann Varanakis (Chief People Officer). Learn More on LifeStance Health Group's active insiders.
Are insiders buying or selling shares of LifeStance Health Group?: In the last twelve months, insiders at the sold shares 21 times. They sold a total of 54,464,182 shares worth more than $469,869,862.51. The most recent insider tranaction occured on September, 2nd when CTO Vukasin Paunovich sold 42,067 shares worth more than $541,402.29. Insiders at LifeStance Health Group own 3.5% of the company. Learn More about insider trades at LifeStance Health Group.
Information on this page was last updated on 9/2/2026.

Vukasin Paunovich Insider Trading History at LifeStance Health Group

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
9/2/2026	Sell	42,067	$12.87	$541,402.29	205,379
8/10/2026	Sell	44,394	$10.85	$481,674.90	247,446

Vukasin Paunovich Buying and Selling Activity at LifeStance Health Group

LifeStance Health Group Company Overview

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.

Today's Range

Now: $12.80

$12.49

$12.91

50 Day Range

MA: $11.58

$10.26

$12.89

2 Week Range

Now: $12.80

$4.77

$13.15

Volume

3,072,999 shs

Average Volume

3,618,075 shs

Market Capitalization

$4.96 billion

P/E Ratio

98.47

Dividend Yield

N/A

Beta

1.22